Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

March-April 2004; Volume 24,Issue 2A

Biotechnology, Cancer and Drug Resistance

  • You have access
    Antivascular and Antitumor Activities of Liposome-associated Drugs
    ROBERT M. STRAUBINGER, ROBERT D. ARNOLD, RONG ZHOU, RICHARD MAZURCHUK and JEANINE E. SLACK
    Anticancer Research March 2004, 24 (2A) 397-404;
  • You have access
    Adriamycin Alters the Expression of Drug Efflux Pumps and Confers Amphotericin B Tolerance in Candida albicans
    JOSEPH O'KEEFFE and KEVIN KAVANAGH
    Anticancer Research March 2004, 24 (2A) 405-408;
  • You have access
    Structure-activity Analysis of Taxane-based Broad-spectrum Multidrug Resistance Modulators
    TRACY A. BROOKS, DANIEL R. KENNEDY, DONALD J. GRUOL, IWAO OJIMA, MARIA R. BAER and RALPH J. BERNACKI
    Anticancer Research March 2004, 24 (2A) 409-416;
  • You have access
    5-Fluorouracil: Identification of Novel Downstream Mediators of Tumour Response
    JOHN BOYER, PAMELA J. MAXWELL, DANIEL B. LONGLEY and PATRICK G. JOHNSTON
    Anticancer Research March 2004, 24 (2A) 417-424;
  • You have access
    Construction and Transfection of a Ribozyme Targeting Human Caspase-3
    DEIRDRE CRONIN, CARMEL DALY, TONI O'DOHERTY, MARY HEENAN, KEVIN J. SCANLON and MARTIN CLYNES
    Anticancer Research March 2004, 24 (2A) 425-432;
  • You have access
    Two-deoxyglucose as an Anti-metabolite in Human Carcinoma Cell Line RPMI-2650 and Drug-resistant Variants
    J KEENAN, Y LIANG and M CLYNES
    Anticancer Research March 2004, 24 (2A) 433-440;
  • You have access
    Microarrays in Cancer Research
    GERALDINE M. GRANT, AMANDA FORTNEY, FRANCESCO GORRETA, MICHAEL ESTEP, LUCA DEL GIACCO, AMY VAN METER, ALAN CHRISTENSEN, LAKSHMI APPALLA, CHAHLA NAOUAR, CURTIS JAMISON, ALI AL-TIMIMI, JEAN DONOVAN, JAMES COOPER, CARLETON GARRETT and VIKAS CHANDHOKE
    Anticancer Research March 2004, 24 (2A) 441-448;
  • You have access
    Functional Studies on the MRP1 Multidrug Transporter: Characterization of ABC-signature Mutant Variants
    ZS. SZENTPÉTERY, B. SARKADI, É. BAKOS and A. VARADI
    Anticancer Research March 2004, 24 (2A) 449-456;
  • You have access
    Increased Anti-tumour Efficacy of Doxorubicin when Combined with Sulindac in a Xenograft Model of an MRP-1-positive Human Lung Cancer
    ROBERT O'CONNOR, MARY HEENAN, LISA CONNOLLY, ANNEMARIE LARKIN and MARTIN CLYNES
    Anticancer Research March 2004, 24 (2A) 457-464;
  • You have access
    Cellular Models of Drug- and Radiation-resistant Small Cell Lung Cancer
    ROSS A. DAVEY, VICKI L. LOCKE, SHERIDAN HENNESS, ROZELLE M. HARVIE and MARY W. DAVEY
    Anticancer Research March 2004, 24 (2A) 465-472;
  • You have access
    Expression and Prognostic Relevance of Mcl-1 in Breast Cancer
    L. O'DRISCOLL, D. CRONIN, S.M. KENNEDY, R. PURCELL, R. LINEHAN, S. GLYNN, A. LARKIN, K. SCANLON, E.W. MCDERMOTT, A.D. HILL, N.J. O'HIGGINS, M. PARKINSON and M. CLYNES
    Anticancer Research March 2004, 24 (2A) 473-482;
  • You have access
    A Novel Gene Delivery System for Mammalian Cells
    BRIAN GIBSON, ANGELA M. DUFFY, SUSAN GOULD FOGERITE, SARA KRAUSE-ELSMORE, RUYING LU, GAOFENG SHANG, ZI-WEI CHEN, RAPHAEL J. MANNINO, DAVID J. BOUCHIER-HAYES and JUDITH H. HARMEY
    Anticancer Research March 2004, 24 (2A) 483-488;
  • You have access
    Increased Invasion and Expression of MMP-9 in Human Colorectal Cell Lines by a CD44-dependent Mechanism
    DAVID MURRAY, MARY MORRIN and SUSAN MCDONNELL
    Anticancer Research March 2004, 24 (2A) 489-494;
  • You have access
    Activity of Novel Plant Extracts Against Medullary Thyroid Carcinoma Cells
    BEATE RINNER, VERONIKA SIEGL, PETER PÜRSTNER, THOMAS EFFERTH, BRIGITTE BREM, HARALD GREGER and ROSWITHA PFRAGNER
    Anticancer Research March 2004, 24 (2A) 495-500;
  • You have access
    Cancer Gene Therapy: Challenges and Opportunities
    KEVIN J. SCANLON
    Anticancer Research March 2004, 24 (2A) 501-504;
  • You have access
    ABSTRACTS OF THE INTERNATIONAL CONFERENCE “BIOTECHNOLOGY, CANCER AND DRUG RESISTANCE: NEW TARGETS, NEW DIAGNOSIS AND NEW TREATMENT FOR TUMOURS RESISTANT TO CURRENT THERAPIES” 7-8 July, 2003 Clontarf Castle, Dublin, Ireland
    Anticancer Research March 2004, 24 (2A) 505-538;
Back to top
PreviousNext

In this issue

Anticancer Research: 24 (2A)
Anticancer Research
Vol. 24, Issue 2A
March-April 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire